Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Analytical Cellular Pathology is Scopus-indexed (Q1, CiteScore 5.8), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2210-7177Verify ISSN ↗2210-7185Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 39 / 209 | 81st | Q1 |
| Cancer Research | 102 / 233 | 56th | Q2 |
| Molecular Medicine | 85 / 179 | 52nd | Q2 |
| Cell Biology | 147 / 289 | 49th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 5.8.
Analytical Cellular Pathology is Q1 in Pathology and Forensic Medicine (rank 39 of 209), Q2 in Cancer Research (rank 102 of 233) and Q2 in Molecular Medicine (rank 85 of 179), by CiteScore 2025. It is ranked in 4 subject areas in all.
Analytical Cellular Pathology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.709, quartile Q2, with an H-index of 41.
The publisher lists an article processing charge of about US$2,160 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Analytical Cellular Pathology is published by John Wiley and Sons Inc. Its print ISSN is 2210-7177 and its online ISSN is 2210-7185.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Analytical Cellular Pathology has an h-index of 60 and a 2-year mean of 1.6 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #76 of 208 Scopus journals in Pathology and Forensic Medicine.
Analytical Cellular Pathology published 34 papers in 2025; its busiest recent year was 2022 with 77. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from China (70.2%), Iran (6.6%) and Türkiye (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 26 retracted papers are recorded (20.3 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.